Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II)

Abstract

Background: Pharmacokinetic (PK) models can describe microvascular density and integrity. An essential component of PK models is the arterial input function (AIF) representing the time-dependent concentration of contrast agent (CA) in the blood plasma supplied to a tissue. Purpose/Hypothesis: To evaluate a novel method for subject-specific AIF estimation that takes inflow effects into account. Study Type: Retrospective study. Subjects: Thirteen clinical patients referred for spine-related complaints; 21 patients from a study into luminal Crohn's disease with known Crohn's Disease Endoscopic Index of Severity (CDEIS). Field Strength/Sequence: Dynamic fast spoiled gradient echo (FSPGR) at 3T. Assessment: A population-averaged AIF, AIFs derived from distally placed regions of interest (ROIs), and the new AIF method were applied. Tofts' PK model parameters (including v_p and K^trans) obtained with the three AIFs were compared. In the Crohn's patients K^trans was correlated to CDEIS. Statistical Tests: The median values of the PK model parameters from the three methods were compared using a Mann–Whitney U-test. The associated variances were statistically assessed by the Brown-Forsythe test. Spearman's rank correlation coefficient was computed to test the correlation of K^trans to CDEIS. Results: The median v_p was significantly larger when using the distal ROI approach, compared to the two other methods (P < 0.05 for both comparisons, in both applications). Also, the variances in v_p were significantly larger with the ROI approach (P < 0.05 for all comparisons). In the Crohn's disease study, the estimated K^trans parameter correlated better with the CDEIS (r = 0.733, P < 0.001) when the proposed AIF was used, compared to AIFs from the distal ROI method (r = 0.429, P = 0.067) or the population-averaged AIF (r = 0.567, P = 0.011). Data Conclusion: The proposed method yielded realistic PK model parameters and improved the correlation of the K^trans parameter with CDEIS, compared to existing approaches. Level of Evidence: 3. Technical Efficacy Stage 1. J. Magn. Reson. Imaging 2018;47:1197–1204.